Article
Blood transcriptomic signature in type-2 biomarker-low severe asthma and asthma control
12 Jun 2023
Abstract excerpt
BACKGROUND: Patients with type-2 (T2) cytokine-low severe asthma often have persistent symptoms despite suppression of T2 inflammation with corticosteroids. OBJECTIVES: We sought to analyze whole blood transcriptome from 738 samples in T2-biomarker-high/-low patients with severe asthma to relate transcriptomic signatures to T2 biomarkers and asthma symptom scores. METHODS: Bulk RNA-seq data were generated for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
